About The Project
The Irvine project is a key contributor to this target particularly given the high energy requirements generated at this GSK facility.
Technologies Used
In addition to the existing two wind turbines owned by GSK, the development provides the following additional technologies:
8MW of Wind
(2 Enercon E126 EP3 turbines, with a tip height of 150m)
20MW of Field Scale Solar
(Installation of approximately 45,000 modules)
Planning
Consent was granted by North Ayrshire Council in 2019. This was achieved through unanimous approval at Planning Committee following ongoing and detailed discussions with the Local Planning Authority and Statutory Consultees during the determination period.
This ensured concerns regarding Glasgow Prestwick Airport's radar, landscape and visual impact and ecology were dealt with collaboratively and efficiently.
Key Benefits
The project represents significant investment in the local area, injecting investment into the local economy and creating temporary construction jobs and operational jobs.
Furthermore, the provision of renewable energy solutions to the GSK plant will secure future investment into this substantial local employer to secure long term job security for staff.
Outcomes
Construction was completed in 2024 and connected directly to the energy offtaker.
All of the power will be sold to GSK under a long term PPA agreement providing a long term, low cost renewable energy solution.
